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Abstract 21 
Lactate metabolism was studied in mixed bacterial communities using single stage 22 
continuous flow fermentors inoculated with faecal slurries from four different volunteers 23 
and run for 6 days at pH 5.5 and 6.0, using carbohydrates, mainly starch, as substrates. A 24 
continuous infusion of [U-13C]starch and L-[3-13C]lactate was performed on day 5 and a 25 
bolus injection of L-[3-13C]lactate plus DL-lactate on day 6. Short chain fatty acids and 26 
lactate concentrations plus enrichments and numbers of lactate producing and utilizing 27 
bacteria on day 5 were measured. Faecal samples were also collected weekly over a 3-28 
month period to inoculate 24h-batch culture incubations at pH 5.9 and 6.5 with 29 
carbohydrates alone or with 35 mmol L-1 lactate. In the fermentors, potential lactate 30 
disposal rates were more than double formation rates, and lactate concentrations usually 31 
remained below detection. Lactate formation was greater (P < 0.05) at the lower pH with a 32 
similar tendency for utilization. Up to 20% of butyrate production was derived from 33 
lactate. In batch cultures lactate was also efficiently used at both pH values, especially at 34 
6.5, although volunteer and temporal variability existed. Under healthy gut environmental 35 
conditions, bacterial lactate disposal seems to markedly exceed production. 36 
37 
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Introduction 38 
The metabolic activities of gut bacteria have a considerable influence in human health 39 
and disease (Guarner & Malagelada, 2003). Dietary carbohydrate substrates, including 40 
starch (Jacobasch et al., 1999), that escape digestion by host enzymes may be fermented by 41 
microbes to short chain fatty acids (SCFA) in the colon. Acetate is the predominant 42 
product of such fermentation but may also be converted to butyrate by several bacterial 43 
species in the colon by the action of butyryl CoA: acetate CoA transferase (Pryde et al., 44 
2002; Duncan et al., 2004a; Louis et al., 2004). Butyrate, which is not further metabolised 45 
by microbes in the colon (Belenguer et al., 2008), is the preferred energy source for the 46 
colonocytes (Pryde et al., 2002; Gill & Rowland., 2002) and may help ameliorate 47 
inflammation and prevent colorectal cancer (McIntyre et al., 1993; Tazoe et al., 2008; 48 
Hamer et al., 2008; Louis & Flint, 2009).   49 
Propionate is the other major fermentation product detected in the colon whilst  lactate 50 
is an intermediate product usually found in low concentrations in faecal samples from 51 
healthy subjects (< 5 mmol L-1) due to further microbial utilization and conversion to 52 
butyrate, propionate or acetate (Belenguer et al., 2007). Lactate is a product of several 53 
bacterial groups, including bifidobacteria (Florent et al., 1985) and certain anaerobes 54 
(Mcfarlane & Gibson, 1991; Duncan et al., 2002). At low concentrations lactate is 55 
considered beneficial in the colon as the low pKa makes it inhibitory to pathogens. Lactate, 56 
however, may accumulate to high concentrations (up to 90 mmol L-1) in the colonic lumen 57 
of ulcerative colitis sufferers (Vernia et al., 1988) with detrimental effects, including 58 
neurotoxic responses (Ewarschuk et al., 2005).  59 
Among the factors that affect the gut microbial ecosystem, pH impacts markedly on the 60 
composition and metabolism of the colonic microbiota (Walker et al., 2005; Duncan et al., 61 
2009). This is also the case for lactate metabolism and previous studies have shown that 62 
lactate production and utilization are maintained in balance by mixed human faecal 63 
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bacteria (Bourriaud et al., 2005; Morrison et al., 2006), within the normal physiological pH 64 
range (Belenguer et al., 2007). At pH 5.2, however, lactate utilization was curtailed and 65 
this metabolite accumulated (Belenguer et al., 2007). This may explain high lactate 66 
concentrations in severe colitis (Vernia et al., 1988) where the colonic pH can approach 67 
that of the stomach (Fallingborg et al., 1993). The contribution of various bacterial species 68 
to lactate utilization remains ill-defined, however, but several are known to convert lactate 69 
to propionate or butyrate (Duncan et al., 2004b; Morrison et al., 2006; Falony et al., 2006). 70 
These include Eubacterium hallii, Anaerostipes caccae and an un-named species (Duncan 71 
et al., 2004b) that are butyrate-producing bacteria and belong to the dominant core group 72 
of species in the human intestinal microbiota (Tap et al., 2009; Walker et al., 2010).  73 
 74 
Maintenance of low amounts of lactate within the colon represents a balance between 75 
utilization and production and imbalances in either can cause lactate accumulation. The 76 
current study uses two approaches, long-term (6 days) continuous fermentors and short 77 
term (24h) batch cultures to estimate rates of lactate production and utilization and 78 
determine if these link to certain bacterial groups. The pH of the culture media was shown 79 
to modify rates of lactate metabolism and stable isotope approaches were used to allow 80 
quantification of flow from starches to lactate and to end-product metabolites.    81 
 82 
Material and methods 83 
Collection of faecal samples  84 
These were provided by four adult volunteers (two male and two female), aged 32-62 85 
years and all consuming a Western style diet. The volunteers (referred to as donors A, B, C 86 
and D) did not take any antibiotics or drugs known to influence faecal microbiota for the 87 
last 6 months prior to the start of the studies.  88 
 89 
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Continuous flow fermentor incubations  90 
Single-stage continuous fermentor systems were operated as described previously 91 
(Duncan et al., 2003) using a medium based on that of Macfarlane et al. (1989) as 92 
modified by Walker et al. (2005). The carbon sources present in the mixed substrate 93 
medium were potato starch (0.5% weight in volume, w/v) in addition to xylan, pectin, 94 
amylopectin and arabinogalactan each at 0.06% (w/v). The total peptide concentrations 95 
(comprising equal amounts of casein hydrolysate and peptone water) were 0.2%. The 96 
fermentor growth medium was maintained under a stream of CO2 with a flow rate of fresh 97 
medium equating to one pool per day, giving a dilution rate of 0.042 h-1. Prime doses of 98 
SCFA were added to give initial concentrations of approximately 35 mmol L-1 acetate, 9 99 
mmol L-1  propionate, 5 mmol L-1 butyrate and 1 mmol L-1 each of valerate, iso-valerate, 100 
and iso-butyrate, but were not included in the supplied medium. The pH was maintained at 101 
either 5.5 ± 0.1 (vessel 1) or 6.0 ± 0.1 (vessel 2). The temperature was maintained at 37ºC 102 
using a thermal jacket. Faecal suspensions (20%) were prepared by suspending fresh faecal 103 
samples in 50 mmol L-1 phosphate buffer (pH 6.5) containing 0.05% cysteine under O2-104 
free CO2 to give a faecal inoculum of 2% (w/v) in the vessel. Substrate (mixture of 105 
carbohydrates) was infused continuously, with potato soluble starch being supplied at 106 
approximately 16 and 22 mg h-1 (which would be equivalent to approximately 92 and 124 107 
µmol glucose h-1) in vessels 1 and 2, respectively.  108 
For the lactate metabolism studies a continuous infusion of [U-13C]starch (equivalent to 109 
7.35-8.83 and 10.95-17.00 µmol glucose h-1 in vessels 1 and 2, respectively) and L-[3-110 
13C]lactate (5.29-6.58 and 6.58-7.88 µmol h-1 in vessels 1 and 2, respectively) was 111 
performed for 10 h on day 5, with a prime injection of  [1-13C]acetate (184.2-384.8 and 112 
219.4-298.6 µmol in vessels 1 and 2, respectively), [1,2-13C]acetate (176.9-402.3 and 113 
195.7-296.4 µmol in vessels 1 and 2, respectively) and [1-13C]propionate (9.4-22.2 and 114 
7.6-21.7 µmol in vessels 1 and 2, respectively) given approximately 4 h after the start of 115 
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the infusion of labelled starch and lactate. The following day (day 6) both vessels received 116 
a bolus injection of L-[3-13C]lactate (approximately 23 and 28 µmol in vessels 1 and 2, 117 
respectively) plus DL-lactate (approximately 230 and 275 µmol in vessels 1 and 2, 118 
respectively). 119 
Daily samples were taken from each vessel to monitor SCFA and lactate concentrations. 120 
On the infusion day (day 5) samples were taken every 30 min for the first 3 h of the 121 
infusion and hourly thereafter until 10 h to measure SCFA and lactate concentrations and 122 
metabolite 13C enrichments. On the injection day (day 6) samples were taken at 30 min 123 
intervals from just before until 4 h after the bolus injection, with lactate concentrations and 124 
metabolite 13C enrichments measured.  125 
 126 
Batch culture incubations  127 
Fresh faecal samples from the same four volunteers (A, B, C and D) were collected 128 
weekly at 12 occasions over a three month period. Slurries of this material were used for 129 
batch culture incubations with an anaerobic medium similar to that used for the continuous 130 
flow fermentor incubations, based on Macfarlane et al. (1989) as modified by Walker et al. 131 
(2005). The carbohydrate sources present in the mixed substrate medium were potato 132 
starch (0.14% w/v) in addition to xylan, pectin, amylopectin, and arabinogalactan each at 133 
0.015% (w/v). The total peptide concentrations (comprising equal amounts of casein 134 
hydrolysate and peptone water) were 0.2%. Samples were inoculated at two different pH 135 
values (mean ± standard deviation 5.9 ± 0.2 and 6.5 ± 0.2) and with either a carbohydrate 136 
mixture alone or with DL-lactate (approximately 35 mmol L-1 initial concentration) also 137 
present. SCFA were also added to the medium to give initial concentrations of 138 
approximately 33 mmol L-1 acetate, 9 mmol L-1 propionate, 5 mmol L-1 butyrate and 1 139 
mmol L-1 each of valerate, iso-valerate, and iso-butyrate. The fermentor medium was 140 
dispensed into Hungate tubes under a stream of CO2 (Miyazaki et al., 1997) and heat 141 
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sterilised at 121 oC (15 min). After cooling, heat-labile vitamins were added and the 142 
medium was inoculated with the faecal slurry under CO2 and incubated at 37 ºC. Faecal 143 
slurries (20%) were prepared within 2 h of collection in anaerobic phosphate buffer saline 144 
to give a final concentration of approximately 0.2%. Tubes were inoculated in duplicate 145 
and samples were taken at 24 h to measure SCFA and lactate concentrations. Samples of 146 
uninoculated medium were also taken to measure initial concentrations and initial pH 147 
values.  148 
 149 
Quantification of bacteria in faecal and continuous fermentor samples by 150 
fluorescent in situ hybridization analysis  151 
Samples were taken from faeces (0.5 g) and the fermentor incubations on day 5 (1 ml) 152 
for fluorescent in situ hybridization (FISH) analysis. Faecal samples were diluted with 153 
phosphate buffer (1:10), and all samples were fixed by mixing 1:3 in 4% (w/v) 154 
paraformaldehyde at 4°C for 16 h and stored at -20°C. FISH analysis was performed as 155 
described by Harmsen et al. (2002). Diluted cell suspensions were applied to gelatin-156 
coated slides and the slides were hybridized overnight with the appropriate probes. 50 µl of 157 
Vectashield (Vector Laboratories, Burlingame, CA) was applied to each slide to prevent 158 
fading. Cells were counted automatically using image analysis software CellF (Olympus 159 
Soft Imaging Solutions GmbH, Germany) with an Olympus microscope, except when the 160 
number of cells was less than 10 per field of view, in which case the cells were counted 161 
manually. For each sample 30 microscopic fields were counted and the data averaged. All 162 
samples were assessed with the following probes: total bacteria (Eub338, Amann et al., 163 
1990), Bifidobacterium spp. (Bif164, Langendijk et al., 1995), as lactate-producing 164 
bacteria, and the Eubacterium hallii (Ehal1469, Harmsen et al., 2002) and Anaerostipes 165 
caccae (Acac194, Hold et al., 2002) groups, as potential lactate utilisers. 166 
 167 
8 
 
Determination of concentrations and 13C enrichments in short chain fatty acids 168 
and lactate  169 
Daily samples from the single-stage continuous fermentors were derivatised in duplicate 170 
for estimation of concentrations of SCFA and lactate by capillary gas chromatography 171 
(Richardson et al., 1989). Similar analyses were performed for blank and 24h samples 172 
from the batch culture incubations to measure lactate concentrations. Samples from the 173 
fermentors on the infusion day (day 5) were analysed for lactate and SCFA concentrations 174 
and enrichments but only lactate concentrations and enrichments were determined in the 175 
samples collected during the injection day (day 6). For samples from both day 5 and 6 176 
concentrations were quantified by isotope dilution, while enrichments were measured by 177 
gas chromatography-mass spectrometry analysis of the tert-butyldimethylsilyl derivatives, 178 
as described previously (Duncan et al., 2004a; Belenguer et al., 2006). Analyses were 179 
under electron impact ionisation conditions; for acetate, the ions M+, M+1 and M+2 at 180 
mass/charge (m/z) 117, 118 and 119 were monitored; for butyrate, M+, M+1, M+2 and 181 
M+4 (i.e. m/z 145, 146, 147 and 149) were determined, the latter to quantify butyrate 182 
formation from two [1,2-13C] acetate molecules; for propionate, M+, M+1, M+2 and M+3 183 
(i.e. m/z 131, 132, 133 and 134) were measured; for  lactate, M+, M+1, M+2 and M+3 ion 184 
fragments were analysed (m/z 261, 262, 263 and 264). For the concentration 185 
determinations appropriate corrections were applied for the enrichments of the samples. 186 
 187 
Metabolic activities of pure cultures of bacteria  188 
Based on data reported previously (Belenguer et al., 2006) rates of conversion of 0.2% 189 
(w/v) starch substrate to lactate in batch cultures were calculated at pH 5.7 and 6.7 between 190 
4 and 8 h of incubation. Similarly the activity of E. hallii to utilise lactate was determined 191 
in the presence of 45 mmol L-1 lactate at pH 5.7 and 6.7 between 8 and 24 h of incubation. 192 
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For both species, the number of bacteria in the respective incubations was determined by 193 
optical density (1 OD600=109 cells; Lech et al., 1987). 194 
 195 
Kinetic modelling  196 
The model structure and fates of the various isotopes are shown in Fig. 1. Let q, Q, and 197 
E denote the labelled amount (µmol), the total (labelled plus unlabelled) amount (µmol) 198 
and enrichment (0.01 molar % excess, MPE) of either acetate, butyrate, propionate, lactate, 199 
or starch, denoted by subscripts ‘a’, ‘b’, ‘p’, ‘l’ and ‘s’, respectively. Let i denote the 200 
interval between any two times t0 and t1, with t1 > t0, and let F(i) denote the flow of a 201 
metabolite (labelled plus unlabelled) during i. Eff(i) denotes the loss to the effluent during 202 
interval i, and E(i) denotes the average enrichment during i. Subscript ‘in’ refers to inflow 203 
(production) and subscript ‘out’ refers to use in further metabolic processes (e.g. acetate 204 
used to produce butyrate). For example, Fa.in refers to acetate production, while Fa.out stands 205 
for acetate outflow, etc. Flows to pool y from pool x are denoted by Fyx. Q, q, E and Eff 206 
were measured, whilst the Fyx, Fin and Fout were unknown.  207 
Data are expressed in terms of two carbon (C2) units, to allow for ‘molar equivalent’ 208 
transfers. To achieve this, the concentration of butyrate is multiplied by 2 and the 209 
enrichment divided by 2. The enrichments of propionate and lactate, in terms of C2 units, 210 
are given as 0.01 (MPE(M+2) + MPE(M+3)).  The concentrations of acetate, propionate 211 
and lactate and their M+1 enrichments are as measured directly.  212 
 213 
Infusion day (day 5): 214 
Calculations are based on time points during the continuous infusion of labelled starch 215 
and lactate between 4 and 10 h, after the prime doses of labelled acetate and propionate. 216 
Lactate formation (Fl.in) and utilisation (Fl.out) were obtained from the changes in labelled 217 
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(M+1) and total (labelled plus unlabelled) lactate as observed during the continuous 218 
infusion of [3-13C]lactate: 219 
ql.m+1(t1) = ql.m+1(t0) + Infusion(i) – El.m+1(i) Fl.out(i)  – El.m+1(i) Effl(i) (1) 220 
Ql(t1) = Ql(t0) + Infusion(i) + Fl.in(i) – Fl.out(i) – Effl(i)   (2) 221 
 222 
It was assumed that butyrate was formed (Fb.in) via two pathways, either through the 223 
extracellular acetate pool (Fba) or directly from lactate (Fbl). First, from the changes in the 224 
total butyrate concentration Fb.in was obtained: 225 
 Qb(t1) = Qb(t0) + Fb.in(i) – Effb(i)      (3) 226 
Then, changes in the M+1 enriched butyrate were modelled as 227 
qb.m+1(t1) = qb.m+1(t0) + El.m+1(i) Fbl(i) + Ea.m+1(i) Fba(i) – Eb.m+1(i) Effb(i) (4) 228 
Writing Fba = Fb.in – Fbl and substituting in equation (4) then provides Fbl, and Fba 229 
follows.  230 
 231 
The total production of propionate (Fp.in) was obtained from 232 
Qp(t1) = Qp(t0) + Fp.in(i) – Effp(i)       (5) 233 
where it was assumed that propionate has no further metabolic fates, i.e. Fp.out = 0. 234 
Changes in labelled propionate derived from 3-13C-lactate were modelled as: 235 
qp.m+1(t1) = qp.m+1(t0) + El.m+1(i) Fpl(i) – Ep.m+1(i) Effp(i)   (6) 236 
which then provided an estimate for Fpl.  237 
 238 
The incorporation of lactate into acetate (Fal) is obtained from assuming that lactate may 239 
be utilised only to produce acetate, butyrate and propionate:  Fl.out = Fal + Fbl + Fpl. 240 
Furthermore, the M+1 acetate movements yield an estimate for Fa.out, based on: 241 
 qa.m+1(t1) = qa.m+1(t0)  + El.m+1(i) Fal(i)  – Ea.m+1(i) Fa.out(i)– Ea.m+1(i) Effa(i)   (7) 242 
Fa.in follows from 243 
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Qa(t1) = Qa(t0) + Fa.in(i) – Fa.out(i) – Effa(i)     (8) 244 
 245 
Incorporation of starch into acetate (Fas), lactate (Fls) and propionate (Fps) was obtained 246 
from the changes in labelled metabolites that were produced from the infused [U-13C] 247 
starch. For Fls:  248 
ql.m+2(t1) = ql m+2 (t0) + Es Fls(i)– El.m+2(i) Fl.out(i) – El.m+2(i) Effl(i)   (9) 249 
Here it is assumed that both M+2 and M+3 lactate were formed from [U-13C]starch (i.e. 250 
El.m+2 = 0.01 MPElactate(M+2) + 0.01 MPElactate(M+3)). Making similar assumptions for 251 
propionate, Fps follows from: 252 
qp.m+2(t1) = qp.m+2(t0) + El.m+2(i) Fpl(i) + Es(i) Fps(i) – Ep.m+2(i) Effp(i)  (10) 253 
Incorporation of starch into acetate follows from: 254 
qa.m+2(t1) = qa.m+2(t0)  + El.m+2(i) Fal(i)  + Es Fas(i) – Ea.m+2(i) Fa.out(i) – Ea.m+2(i) Effa(i)   255 
(11) 256 
 257 
Bolus injection of labelled lactate (day 6): 258 
Except in the vessel at the lower pH (5.5) inoculated with a faecal suspension from 259 
volunteer A, no lactate was detected so that lactate enrichments El.m+1 and El.m+2 could not 260 
be determined.  Estimates of lactate formation were based, instead, on samples collected 261 
following the bolus injection of [3-13C]lactate on day 6. Lactate utilisation (Fl.out) on day 6 262 
was obtained from the changes in labelled (M+1) lactate (based on equation (1), with 263 
‘Infusion’ set equal to zero). This was then used to obtain Fl.in, based on changes in total 264 
(labelled plus unlabelled) lactate (equation (2), with ‘Infusion’ set to zero). The remaining 265 
calculations are based on the day 5 measurements, as follows.  It was assumed that Fl.in was 266 
the same on days 5 and 6 and this was substituted in equation (2) to derive Fl.out on day 5.  267 
Subsequently, an estimate of the lactate M+1 enrichment on day 5, denoted by E*l.m+1, was 268 
obtained from E*l.m+1 = Infusion rate / (Fl.in + Infusion rate), assuming that the infusate was 269 
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fully labelled. In subsequent calculations, E*l.m+1 replaced El.m+1, so that Fbl, Fba,  Fpl, Fal, 270 
Fa.out and Fa.in could be calculated as before, based on equations (4), (6)-(8).  To estimate 271 
the fates of starch, it was assumed that 40% of the lactate came from starch, so that the 272 
lactate M+2 enrichment was assumed to be 0.4 of the starch enrichment.  This estimate of 273 
the lactate M+2 enrichments, denoted as E*l.m+2, then replaced El.m+2 in equations (9) – (11) 274 
to provide estimates for Fls, Fps and Fas. Note that Fb.in and Fp.in (equations (3) and (5) 275 
respectively) are unaffected by any of the assumptions.  276 
The assumption of Fl.in on day 5 being equal to that on day 6 was supported by data from 277 
donor A at pH 5.5 (0.29 and 0.28 µmol mL-1 h-1 respectively. Data from the same volunteer 278 
showed that approximately 40% of the lactate came from starch and this value was applied 279 
to the other volunteers. Based on the model adopted, this assumption should only influence 280 
the calculation of Fls, Fps and Fas. In practice, sensitivity analysis with the proportion of 281 
lactate from starch varied from 1 to 99% only impacted seriously on Fas, Fps and Fpx, with 282 
the coefficient of variation lower than 36%, except for Fpx that showed flows lower than 283 
0.15 µmol mL-1 h-1. 284 
 285 
Statistical analysis  286 
Where SCFA data were replicated the average values were used. The daily SCFA data 287 
from the continuous fermentors were analysed as repeated measures, with volunteer and 288 
time point nested within volunteer as random effects, while time point, pH and their 289 
interaction were taken as fixed effects. The weekly lactate data from the batch culture 290 
incubations were analysed using the same random structure, but with fixed effects now 291 
consisting of time point, pH, substrate and their interactions. To account for dependency on 292 
previous time points, a suitable covariance structure (compound symmetry) was fitted on 293 
the basis of Schwarz’s Bayesian information model fit criterion. Quantities (such as carbon 294 
flows, numbers of bacteria) obtained from the day 5 (or day 6) data in the continuous 295 
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fermentors were analysed as one-way analysis of variance with volunteer as random effect 296 
and pH as fixed effect. Pure culture data on lactate formation and utilization were also 297 
analysed as one-way analysis of variance with pH as fixed effect. P < 0.05 was regarded as 298 
statistically significant. All data were analysed using the MIXED procedure of the SAS 299 
software package, version 9.1 (SAS Inst. Inc., Cary, NC). In addition, the linear 300 
relationships between variables of interest were analysed using the REG procedure of the 301 
SAS software. 302 
 303 
Results 304 
Concentrations of SCFA and lactate over time in continous flow fermenters 305 
Daily concentrations of SCFA (acetate, propionate, butyrate) and lactate in the single 306 
stage fermentors are presented in Fig. 2. SCFA and lactate concentrations required 3 to 4 307 
days to stabilise in all vessels. Lactate was usually detectable only during the first two days 308 
and reduced to negligible amounts by day 3. For other SCFA (data not shown) succinate 309 
was occasionally detected, albeit at low concentrations, whereas formate had variable 310 
initial values (up to 4 mmol L-1) on day 1 but these decreased to zero by day 3. Volunteer 311 
A at pH 5.5 showed a different pattern to the other volunteers, with butyrate nearly 312 
undetectable (< 0.4 mmol L-1) by 3 days, while lactate was detectable throughout and 313 
formate was present at approximately 11 mmol L-1 from day 3 onwards.  314 
 315 
Rates of lactate formation and utilisation  316 
Originally it was expected that lactate concentrations would be above the limits of 317 
detection but, in practice, this only occurred at day 5 for volunteer A at pH 5.5. This 318 
volunteer provided the only direct comparison of metabolism on days 5 and 6, with 319 
endogenous lactate formation similar on both days (0.29 and 0.28 µmol mL-1 h-1 320 
respectively). For the other samples, therefore, the various rates of lactate metabolism were 321 
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calculated based on formation determined on day 6 (Table 1) plus metabolite masses and 322 
enrichments from day 5. These parameters of endogenous lactate metabolism are presented 323 
in Table 2.  324 
Lactate formation was consistently greater at the lower pH (P < 0.05; Tables 1 and 2) 325 
and a similar trend (P = 0.053) was also seen for endogenous lactate utilization (Table 2). 326 
As expected, rates of production and utilization were closely matched to maintain constant 327 
lactate concentrations, even below the limit of detection.  328 
 329 
Carbon flows between starch, lactate and SCFA in continous fermentors 330 
The continuous infusion of [U-13C]starch and [3-13C]lactate, together with the bolus 331 
injection of [1,2-13C]acetate, [1-13C]acetate and [1-13C]propionate allowed estimation of 332 
flows (expressed as C2 units) between lactate and the main SCFA (acetate, propionate, 333 
butyrate; Table 2). Labelled starch also allowed quantification of the flow to lactate.  334 
Carbon flow through the acetate pool (Fa.in) was considerable (1.7-2.1 µmol mL-1 h-1), with 335 
most (> 53%) derived from sources other than starch (contribution 16 to 42%) or lactate 336 
(contribution < 14%). Flows from starch to lactate (Fls) and from lactate to acetate (Fal) 337 
were greater at the lower pH (P < 0.05). Propionate formation (approximately 0.5 µmol 338 
mL-1 h-1) was independent of pH (P > 0.10) and with the majority derived from starch (> 339 
51% Fps:Fp.in) . Butyrate formation (Fb.in) was similar to propionate formation and was at 340 
least two-fold greater for volunteers C and D than A or B at the lower pH. Most butyrate 341 
derived from lactate (estimated as Fal × Fba/Fa.out) was via the external acetate pool (> 342 
78%), and involved the action of acetyl-CoA transferase. The exception was volunteer A at 343 
the lower pH where no acetate utilisation or butyrate formation was observed and most 344 
propionate derived from  sources (63%) other than starch (21%) or lactate (16%). 345 
The proportions of lactate carbon converted to acetate, propionate and butyrate were 346 
also estimated (Table 3). The proportion of lactate converted to propionate was always 347 
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greater at pH 6 (P < 0.05). In contrast, the proportion of lactate metabolised to acetate and 348 
butyrate was independent of pH. The fate of lactate also appeared volunteer-dependent. For 349 
one subject (C) butyrate was the main end product whereas for two other volunteers (A and 350 
D) a substantial amount of the lactate (37-68%) was converted to propionate. The 351 
proportion of butyrate formed from lactate, either directly or via the external acetate pool, 352 
varied between 0-20%.  353 
 354 
FISH quantification of bacteria that produce or utilize lactate 355 
Bifidobacterium spp. accounted for 3.8 to 6.1% of the total bacteria present in the fecal 356 
inocula, whereas the populations of the E. hallii group were low and more variable (0.04 to 357 
0.61%) and A. caccae was below the limit of detection (< 0.01%). By d 5 of inoculation, 358 
total bacterial numbers had increased at least 4-fold (Table 4). By this time, for three 359 
volunteers the bifidobacteria accounted for only 0.3 to 4.2% of total bacteria whereas  for 360 
volunteer A the Bifidobacterium spp. contribution was 47% at the lower pH  (an increase 361 
of 8.5×107 g-1). Overall, the log10 numbers of Bifidobacterium spp. only tended to show a 362 
weak relationship with the rate of lactate formation (adjusted r2 = 0.41, P = 0.05). The 363 
populations of the E. hallii group increased over time by 160-fold but these still accounted 364 
for less than 0.7% of the total bacteria and were not affected by pH.     365 
 366 
Effect of pH on lactate metabolism in batch cultures.  367 
A similar mixture of dietary polysaccharides was used for the batch cultures, in the 368 
presence of either 0 or 35 mmol L-1 DL-lactate. The two pH studied were similar, but not 369 
identical, to the fermentor study (5.9 and 6.5). Over the 24h of batch culture, the pH 370 
remained relatively stable (difference between initial and final pH < 0.4). 371 
In the absence of added lactate, net lactate formation or utilisation was in balance for 372 
most cultures at both pH. When lactate was added to the initial medium, net disposal was 373 
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complete in most incubations at pH 6.5 and was always greater (P < 0.001) than at pH 5.9 374 
(Table 5). In the absence of lactate, acetate was the main end product, whereas butyrate 375 
accumulated (P < 0.001) when lactate was present. The presence of lactate also decreased 376 
net production of acetate (P < 0.001) but increased net formation of propionate (P < 377 
0.001).  Furthermore, net production of all three of these SCFA was enhanced at the higher 378 
pH (P < 0.005), although for propionate and butyrate this effect was more pronounced with 379 
the mixture plus lactate than the mixture alone (interaction of substrate x pH, P < 0.001). 380 
Net lactate utilization was also greater at the higher pH, but again this occurred mainly in 381 
the presence of lactate (interaction of substrate x pH, P < 0.001). At the lower pH (5.9) and 382 
with the mixture plus lactate cultures, a linear relationship was observed between net 383 
lactate utilisation and butyrate formation (P < 0.001; adjusted r2 = 0.79; Fig. 3). 384 
 385 
Responses varied between volunteers and weeks. For example, net lactate utilisation 386 
and butyrate production were lower for volunteers C and D than A and B, at the lower pH, 387 
and net formation of propionate and butyrate differed between weeks.  388 
 389 
Activity of pure cultures  390 
Estimates of the equi-cell abilities of B. adolescentis L2-32 to convert starch to lactate 391 
and E. hallii L2-7 to metabolise lactate (to butyrate) are given in Table 6. Both types of 392 
bacteria were more active (P < 0.01) at the lower pH. Nonetheless, at both pH the ability of 393 
E. hallii L2-7 to dispose of lactate exceeded formation by B. adolescentis L2-32 by at least 394 
5-fold.   395 
 396 
Discussion 397 
Kinetics of lactate formation and utilization 398 
17 
 
Although lactate is a known fermentation product of carbohydrate metabolism within 399 
the colon, the concentrations are usually low or undetectable in faecal samples from 400 
healthy donors (Mcfarlane & Cummings, 1991; Vernia et al., 1988; Duncan et al., 2007). 401 
Thus rapid metabolism must also occur. When lactate accumulates, however, as in patients 402 
with severe ulcerative colitis (Vernia et al., 1988; Hove et al., 1994) then, in the absence of 403 
altered rates of absorption (Umesaki et al., 1979), this must be due to changes in either rate 404 
of formation and(or) disposal. Of the many factors that influence microbial lactate 405 
utilisation and production the most important probably  include substrate supply 406 
(Cummings et al., 1989; Duncan et al., 2007), pH (Belenguer et al., 2007; Duncan et al., 407 
2009) and abundance of appropriate bacteria (Roberfroid, 2005). In the present study 408 
substrate supply was fixed and the effect of pH was tested, both on direct metabolism and 409 
via changes in bacterial populations. Use of stable isotopes allowed direct quantification of 410 
lactate production and utilisation as well as the conversion of lactate to propionate or 411 
butyrate, the latter either via butyrate kinase or via the butyryl CoA: acetate CoA 412 
transferase route. Furthermore, co-operative actions between bacteria have been identified 413 
(Wolin et al., 1991; Flint et al., 2007), and including those that produce and utilize lactate 414 
(Duncan et al., 2004b; Belenguer et al., 2006). Therefore, changes in the activity and 415 
population abundances of these bacteria need to be considered alongside the dynamic 416 
quantification of inflows and outflows of specific metabolites. This work suggested that up 417 
to 20% of butyrate production in the mixed community could be derived from lactate 418 
rather than produced directly from carbohydrates. 419 
For the fermentor study, the infusion of carbohydrate was equivalent to approximately 420 
1.7 µmol glucose mL-1 h-1 with a theoretical maximal lactate formation > 3 µmol mL-1 h-1. 421 
In practice, observed rates were much lower (0.06-0.34 µmol mL-1 h-1) indicating that only 422 
a small fraction of the carbohydrate (and peptide) substrates were converted to lactate. In 423 
contrast, the capacity to dispose of lactate appears greater, as shown from the rates of 424 
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disposal observed following a bolus injection of lactate (0.36-0.86 µmol mL-1 h-1, data not 425 
shown). A high estimated minimal rate of disposal (1.47 µmol mL-1 h-1) was observed for 426 
the batch culture incubations with 35 mmol L-1 lactate at both pH 5.9 and 6.5. In both the 427 
fermentor and batch approaches, these values represent a capacity for a rapid response and, 428 
therefore, the inherent disposal capacity of the microorganisms involved exceeds the 429 
ability to produce lactate under the substrate conditions employed with these healthy 430 
volunteers. Nonetheless changes in either process can alter lactate concentrations.  431 
Increased lactate formation has also been observed previously in batch cultures at mild to 432 
moderate acidic pH (studied between 5.2 to 6.4; Belenguer et al., 2007).  These earlier data 433 
(Belenguer et al., 2007) also showed that lactate utilisation was strongly inhibited at pH 434 
5.2 and this would help explain lactate accumulation in colitis patients, where a similar low 435 
pH occurs (Nugent et al., 2001). At higher pH (5.9), however, the mixed faecal microbiota 436 
were able to rapidly utilise lactate (Belenguer et al., 2007) and thus prevent excessive 437 
accumulation. The current data show that even at a more acidic pH (5.5), but still within 438 
the range reported for the proximal large intestine in healthy people (Bown et al., 1974; 439 
Macfarlane et al., 1992), the capacity for lactate utilization still exceeded lactate formation. 440 
Nonetheless, changes in type and supply of fermentable substrate and environmental 441 
conditions influence both bacterial populations and products of their metabolism. For 442 
example, for stool samples collected weekly over 3 months from the free-living volunteers 443 
in this study only in 29/41 cases was lactate detected (at > 1 mmol per kg faecal water). All 444 
volunteers had at least five stools with detectable lactate, and the maximum number of 445 
stools with lactate for any one volunteer was eight (out of 12 collections). Thus, all the 446 
volunteers possessed lactate producers.  447 
 448 
Potential lactate producers and utilizers 449 
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Considering lactate producers, Bifidobacterium spp. (Florent et al., 1985) are major 450 
starch-utilisers within the human colon (Macfarlane & Englyst, 1986; Leitch et al., 2007). 451 
Furthermore, in pure culture, lactate production by bifidobacteria is stimulated at slightly 452 
acidic pH (Table 6; Belenguer et al., 2006). Therefore, it was expected, based on earlier 453 
observations (Levrat et al., 1991; Silvi et al., 1999; Belenguer et al., 2006), that lactate-454 
producing bacteria, such as bifidobacteria, and lactate formation would both be increased 455 
in the fermentors at the lower pH with starch as a substrate.  Nonetheless, the increase in 456 
bifidobacteria at the lower pH was less, relatively, than the change in lactate production 457 
and raises the question of the importance of the bifidobacteria to lactate metabolism. 458 
Although 41% of the variance in lactate formation within the fermentors could be 459 
explained by the numbers (log10) of Bifidobacterium spp. present, the actual numbers of 460 
those bacteria, both in absolute terms and as a percentage of total bacteria, varied between 461 
individuals, as observed previously (Flint et al., 2007). Indeed, when these bacterial 462 
numbers were combined with the rates of lactate production from a starch substrate for 463 
specific Bifidobacterium species (Table 6) then this would account for between 2.8-70% of 464 
lactate formation within the fermentors. The largest contribution occurred with volunteer A 465 
at pH 5.5, who had the greatest abundance of Bifidobacterium spp. (47% at pH 5.5) 466 
whereas for this volunteer at the higher pH and the other three volunteers at both pH only a 467 
maximum of 21% of lactate formation could be accounted by bifidobacteria. These 468 
observations show that other microorganisms make a very important contribution to 469 
lactate-production.  Apart from other lactic acid bacteria such as Lactobacillus spp., 470 
additional bacterial groups known to synthesise lactate are Collinsella spp., E. 471 
rectale/Roseburia spp., Faecalibacterium prausnitzii, and Bacteroides spp. (Macfarlane & 472 
Gibson, 1991; Barcenilla et al., 2000; Duncan et al., 2002). The latter four groups include 473 
the most abundant bacterial species found within the human intestinal microbiota (Tap et 474 
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al., 2009, Walker et al., 2010) and typically account for >50% of total faecal bacteria (e.g. 475 
Duncan et al., 2007). 476 
E. hallii, A. caccae and the new species A. coli (Walker et al., 2010) have been 477 
identified as lactate utilizers (Duncan et al., 2004b) that form butyrate as the end product in 478 
the presence of fermentable polysaccharides (Belenguer et al., 2007).  On an equi-cell 479 
basis, the ability of E. hallii to metabolise lactate exceeds considerably the capacity for 480 
lactate production by bifidobacteria (Table 6), but there was no relationship between E. 481 
hallii abundance and total lactate utilisation (P > 0.10). Furthermore, the near-maximal rate 482 
of lactate disposal by E. hallii (Table 6) when combined with the numbers present in the 483 
fermentors, would only account for 1.2-18.0% of lactate total disposal, with < 4.8% in 484 
most cases. The situation is somewhat different when only lactate converted to butyrate is 485 
considered, however, and where 0-47% could be attributed to the action of E. hallii. Thus, 486 
other bacteria must play important roles in the utilization of lactate, including conversion 487 
to butyrate.  Interestingly, recent evidence indicates that A. coli, that may only utilise D-488 
lactate, is of similar abundance to E. hallii in the human colon (Walker et al., 2010). Other 489 
candidates not detected by the FISH probes used here include Coprococcus catus (Louis & 490 
Flint, 2009) and bacteria related to Megasphaera elsdenii and Eubacterium limosum (Sato 491 
et al., 2008). Involvement of these other bacteria would explain why lactate disposal in the 492 
fermentors (Table 1) was not pH-sensitive and why butyrate was not always the dominant 493 
end-product.  494 
In summary, lactate was efficiently used at two physiological pH, 5.5 and 6.0, in 495 
continuous fermentor systems and, in most cases, exceeded rates of lactate production by 496 
species such as Bifidobacterium. This ability to dispose of lactate in excess of the amounts 497 
normally produced should be viewed as a beneficial trait for the human colon where 498 
moderate to high accumulation of lactate are usually associated with detrimental responses 499 
(Ewaschuck et al., 2005). While some of the key players have been identified, the relative 500 
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importance of different bacterial species in lactate formation and disposal within the 501 
microbial community has still to be established.  502 
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 656 
Table 1. Lactate formation (Fl.in) rates in single stage continuous fermentors inoculated 657 
with faecal suspensions from four different volunteers estimated after a bolus injection of 658 
labelled [3-13C]-lactate plus DL-lactate at two different pH values (5.5 and 6.0) on day 6 of 659 
study. 660 
 Bolus size
a 
(µmol mL-1) 
Fl.in 
(µmol mL-1 h-1) 
Volunteer A   
pH 5.5 2.67 0.28 
pH 6.0 2.32 0.07 
   
Volunteer B   
pH 5.5 2.36 0.19 
pH 6.0 2.32 0.05 
   
Volunteer C   
pH 5.5 2.25 0.09 
pH 6.0 2.56 0.06 
   
Volunteer D   
pH 5.5 2.24 0.34 
pH 6.0 2.26 0.12 
   
SED  0.044 
P for pH  0.043 
a Includes both DL-lactate plus L[13C]lactate.  661 
Data were analysed by analysis of variance, with volunteer as random effect and pH as 662 
fixed effect. 663 
SED, standard error of the difference. 664 
665 
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Table 2. Estimated carbon flows (µmol C2 mL-1 h-1) between starch, lactate, acetate, 666 
propionate and butyrate estimated from the continuous infusion of labelled [13C6]-starch 667 
and [3-13C]-lactate and the bolus injection of [1-13C]-acetate, [1,2-13C]-acetate and [1-13C]-668 
propionate in single stage continuous fermentors inoculated with faecal suspensions from 669 
four different volunteers at two different pH values (5.5 and 6.0). 670 
 pH 5.5 pH 6.0 SED P for pH 
Lactate production (Fl.in) 0.23 0.08 0.044 0.044 
From starch (Fls) 0.09 0.03 0.017 0.043 
From other sources (Flx) 0.14 0.05 0.027 0.044 
Lactate utilization (Fl.out) 0.25 0.13 0.038 0.053 
Acetate production (Fa.in) 2.13 1.72 0.417 0.401 
From starch (Fas) 0.60 0.38 0.207 0.358 
From lactate (Fal) 0.18 0.06 0.027 0.023 
From other sources (Fax) 1.34 1.28 0.261 0.843 
Acetate utilization (Fa.out) 1.09 1.08 0.475 0.987 
Propionate production (Fp.in) 0.48 0.50 0.040 0.657 
From starch (Fps) 0.24 0.33 0.067 0.285 
From lactate (Fpl) 0.07 0.06 0.012 0.669 
From other sources (Fpx) 0.17 0.11 0.061 0.438 
Butyrate production (Fb.in) 0.58 0.35 0.200 0.346 
From acetate (Fba) 0.58 0.35 0.202 0.347 
From lactate (via acetate) 0.071 0.024 0.0220 0.120 
From lactate (direct; Fbl) <0.002 <0.003 0.0025 0.677 
Data were analysed by analysis of variance, with volunteer as random effect and pH as 671 
fixed effect. 672 
SED, standard error of the difference.   673 
674 
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Table 3. Proportion of the different fates of lactate carbon (acetate, propionate, butyrate) 675 
and proportion of butyrate derived from lactate in single stage continuous fermentors 676 
inoculated with faecal suspensions from four different volunteers at two different pH 677 
values (5.5 and 6.0). The proportions of lactate going to butyrate and of butyrate derived 678 
from lactate includes both direct and indirect (via extracellular acetate) routes. 679 
Volunteer A B C D Means   
pH 5.5 6.0 5.5 6.0 5.5 6.0 5.5 6.0 5.5 6.0 SED P for 
pH 
Fates of lactate (%)             
To propionate 37.5 50.5 18.2 37.3 4.8 29.0 36.6 68.5 24.2 46.3 4.00 0.012 
To butyrate (direct 
and via acetate) 
0.0 13.1 35.2 11.0 66.9 38.6 28.8 19.6 32.7 20.6 9.36 0.285 
To acetatea 62.5 36.4 46.6 51.7 28.3 32.4 34.6 11.8 43.0 33.1 8.41 0.324 
Sources of butyrate 
(%) 
            
From lactate (direct 
and via acetate) 
0.0 6.1 20.0 3.8 8.9 12.9 13.4 7.0 10.6 7.5 4.62 0.549 
a Accounts for the lactate-C remaining in acetate, not further metabolized into other 680 
products. 681 
Data were analysed by analysis of variance, with volunteer as random effect and pH as 682 
fixed effect. 683 
SED, standard error of the difference. 684 
685 
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Table 4. Total counts (log10) per ml from inoculation of total bacteria (using the universal 686 
probe Eub338) and the Bifidobacterium spp. and Eubacterium hallii groups (using the 687 
probes Bif164 and Ehal1469) initially and after 5 days of incubating faecal slurries from 688 
four different volunteers in continuous flow fermenters. 689 
 Total numbers (log10) 
 Eub Bif Ehal 
Volunteer A    
Initial counta 7.50 6.13 4.46 
pH 5.5 8.27 7.94 5.36 
pH 6.0 8.34 6.25 5.82 
Volunteer B    
Initial count 7.06 5.69 4.84 
pH 5.5 7.91 6.36 5.70 
pH 6.0 8.31 6.27 5.84 
Volunteer C    
Initial count 7.53 6.11 4.22 
pH 5.5 8.28 6.91 5.48 
pH 6.0 8.60 6.17 6.43 
Volunteer D    
Initial count 7.56 6.35 4.13 
pH 5.5 8.43 6.97 5.76 
pH 6.0 8.35 6.49 5.74 
Means    
Initial count 7.41 6.07 4.41 
pH 5.5 8.22 7.04 5.57 
pH 6.0 8.40 6.30 5.96 
    
SED 0.111 0.336 0.184 
P-value 0.208 0.112 0.128 
a Estimated from faecal counts and taking into account the slurry preparation. 690 
SED, standard error of the difference. 691 
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Table 5. Net formation or utilization of lactate, acetate, propionate and butyrate (in C2 693 
units) in 24 h-incubated batch cultures inoculated with faecal slurries prepared from 4 694 
different healthy volunteers (A, B, C and D) with a mixture of carbohydrates plus 35 mmol 695 
L-1 lactate and at two pH values (5.9 and 6.7). 696 
 697 
  Lactate Acetate Propionate Butyrate 
Mix 5.9 0.54 9.66 1.35 7.47 
 6.5 -0.09 12.6 3.74 6.16 
      
Mix+lactate 5.9 -21.6 2.85 2.80 30.0 
 6.5 -33.6 4.91 8.03 38.8 
      
 SED 0.911 0.598 0.319 1.370 
 pH <0.001 <0.001 <0.001 0.007 
P-value substrate <0.001 <0.001 <0.001 <0.001 
 Week 0.73 0.14 0.003 0.019 
 Substrate x pH <0.001 0.49 <0.001 <0.001 
SED, standard error of the difference. 698 
699 
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 Table 6. Pure culture data for metabolic rates of lactate formation from starch by 700 
Bifidobacterium adolescentis (L2-32) and utilization of lactate by Eubacterium hallii (L2-701 
7). 702 
 703 
 Formation Utilization 
pH µmol 109cells-1 h-1 µmol 109cells-1 h-1 
5.7 2.36 12.07 
6.7 1.23 7.69 
SED 0.219 0.844 
P for pH 0.007 0.007 
SED, standard error of the difference704 
705 
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Fig. 1. Tracer and tracee flows. Assumed to be in C2 units.  Black: tracee flow; Orange: 706 
M+2 and tracee flows; Red: M+2, M+1 and tracee flows. All pools also have loss of 707 
material via the effluent, but this has been omitted from the schematic below. 708 
 709 
Fig. 2. Time course of the concentrations of acetate (diamond), propionate (triangle), 710 
butyrate (circle) and lactate (square) in single stage-fermentor systems at two different pH 711 
values (5.5 and 6.0) using four different volunteers (A, B, C, and D). 712 
 713 
Fig. 3. Relationship between 24h lactate utilisation (mmol L-1) and butyrate formation 714 
(mmol L-1) in batch cultures inoculated with faecal samples from 4 volunteers (different 715 
symbols for each volunteer), with a mixture of carbohydrates and DL-lactate (35.6 mmol 716 
L-1) as substrates at pH 5.9. (P < 0.001 and adjusted r2 = 0.79) 717 
 718 
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Fig. 1. 720 
 721 
 722 
 723 
724 
Extracellular 
acetate 
Lactate 
Fba 
Butyrate 
Propionate 
Fpl Fal 
Fbl 
Starch 
Other 
Fls Fps 
Other 
Other 
Fas 
Intracellular 
acetate 
Fax 
Flx 
Fpx 
 36 
 
725 
Fig. 2.  726 
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 Fig. 3.  737 
 738 
-5
0
5
10
15
20
25
30
35
40
0 5 10 15 20 25 30 35
La
ct
at
e 
ne
t u
til
iz
at
io
n 
(m
m
ol
 L
-1
)
Butyrate net formation (mmol L-1)
 739 
 740 
 741 
